Biological age is an estimate of the body’s state of ageing. The idea is that people born in the same year may have aged differently.
One way to estimate it is to analyse age-related patterns of chemical marks on DNA. These marks are added through a process called DNA methylation. Calculations that turn those patterns into age estimates are known as epigenetic clocks.
In an analysis published in Nature Medicine, researchers compared measurements taken before and after interventions in 51 human studies. Across the lifestyle and medicine categories, they found statistically significant average reductions in the age estimates, with a larger average response for medicines. But different measures did not always tell the same story. These were changes in measurements; whether they correspond to less disease, more years in good health or longer lives remains unclear. Nature Medicine (source, opens in new tab)
Nature MedicineResponsiveness of epigenetic aging biomarkers to longevity interventions in humansOpen source (opens in new tab) Yale School of Medicine (source, opens in new tab)
Yale School of MedicineYale Researchers Create Roadmap To Measure Whether Longevity Interventions WorkOpen source (opens in new tab)
Drawing on 3,128 blood samples, the team examined 16 epigenetic clocks and 94 other biological indicators. All used patterns of DNA methylation. The aim was to identify which measurements respond consistently enough to be useful in future trials.
Mediterranean diets were among the interventions with more consistent responses across studies. A group of medicines used to reduce inflammation also showed more consistent changes in the measurements across studies. These medicines, called anti-TNF therapies, block a protein involved in inflammation. For some supplements, however, the measures moved in different directions: some went up while others went down.
That makes it difficult to describe a supplement as lowering biological age without specifying which measurement changed. For someone interpreting a biological-age test, knowing which clock produced the result is therefore part of understanding what it means.
Many interventions produced no clear change: 26 showed no statistically significant effect. Five showed significant increases in epigenetic-age estimates before adjustment for multiple comparisons.
When researchers make many comparisons, some findings can appear meaningful by chance, so they apply a statistical adjustment to account for this. Nineteen interventions initially showed significant decreases in epigenetic-age estimates. After the adjustment, 13 retained that result.
The studies differed in their participants, duration, design and quality. The authors describe their combined analysis as a way to identify patterns across studies. It does not establish that a particular intervention caused slower ageing.
The analysis can help researchers choose measurements for future trials. Researchers have yet to establish how much a clock reading would need to change to signal a meaningful health benefit. The next question is whether better test results mean better health over time.
- Nature Medicine · Peer-reviewed studyResponsiveness of epigenetic aging biomarkers to longevity interventions in humansnature.com · opens in new tab
- Yale School of Medicine · InstitutionYale Researchers Create Roadmap To Measure Whether Longevity Interventions Workmedicine.yale.edu · opens in new tab